Alterity Therapeutics
ATHE
13 hedge funds and large institutions have $149K invested in Alterity Therapeutics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
30% more funds holding
Funds holding: 10 → 13 (+3)
5% more capital invested
Capital invested by funds: $141K → $149K (+$7.7K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$35K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$18.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$16.9K |
| 4 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
+$59 |
| 5 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.8K |
| 2 |
Morgan Stanley
New York
|
-$5.73K |
| 3 |
CA
CoreCap Advisors
Southfield,
Michigan
|
-$38 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $58.4K | -$5.73K | -3,894 | -8% |
|
|
HWM
2
HB Wealth Management
Atlanta,
Georgia
| $31.2K | +$35K | +23,783 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $18.7K | -$13.8K | -9,379 | -40% |
|
|
4
UBS Group
Zurich,
Switzerland
| $16.6K | +$18.7K | +12,683 | +634,150% |
|
|
5
Citadel Advisors
Miami,
Florida
| $15.4K | +$16.9K | +11,488 | New |
|
|
TLCM
6
Twin Lakes Capital Management
Redwood Shores,
California
| $7.78K | – | – | – |
|
|
PCA
7
Providence Capital Advisors
Charlotte,
North Carolina
| $263 | – | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $105 | – | – | – |
|
|
BTI
9
Blue Trust Inc
Alpharetta,
Georgia
| $72 | +$59 | +40 | New |
|
|
SWM
10
Sugarloaf Wealth Management
Duluth,
Georgia
| $43 | – | – | – |
|
|
SPIA
11
Steward Partners Investment Advisory
New York
| $8 | – | – | – |
|
|
CAS
12
Coppell Advisory Solutions
Coppell,
Texas
| $7 | – | – | – |
|
|
DB
13
Danske Bank
Copenhagen K,
Denmark
| $1 | +$1 | +1 | New |
|
|
CA
14
CoreCap Advisors
Southfield,
Michigan
| – | -$38 | -21 | Closed |
|
ATHE Hedge Fund Activity: Q3 2024 in Review
13 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2024, worth a combined $149K — up 5.5% from $141K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ATHE positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was HB Wealth Management, opening a new position worth an estimated $35K. The largest seller was Susquehanna International Group, cutting an estimated $13.8K.
- 13 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2024, up from 10 in Q2 2024.
- Funds reported $149K of Alterity Therapeutics stock for Q3 2024, up 5.5% quarter-over-quarter.
- 4 funds opened new Alterity Therapeutics positions in Q3 2024 and 1 closed out, a net change of +3 holders.
- The largest Alterity Therapeutics buyer in Q3 2024 was HB Wealth Management, an estimated $35K added.
- The largest Alterity Therapeutics seller in Q3 2024 was Susquehanna International Group, an estimated $13.8K sold.
Based on aggregated 13F filings for Q3 2024.